My insurance denied Wegovy. Are compounded GLP-1s my best option?

Short answer: generally no — compounded GLP‑1s are not the best first option. They carry safety, potency and regulatory risks and aren’t FDA‑approved, so try safer, more reliable routes first.

Why compounded GLP‑1s are risky

• Potency and purity can vary, especially if made from bulk API sourced overseas.
• Injectables require strict sterile compounding (USP <797>); mistakes risk infection.
• No FDA approval or standard labeling, and most insurers won’t cover them.
• The FDA has warned about compounded semaglutide products in the past.

Safer alternatives to try first (with brands/services)

1. Appeal the denial / prior authorization

   • Ask your prescriber to file an appeal or do a peer‑to‑peer with your insurer. Include BMI, comorbidities (diabetes, hypertension, sleep apnea), and prior weight‑loss attempts. This often overturns denials.

2. Manufacturer support and copay assistance

   • Novo Nordisk savings card / patient support for Wegovy (check eligibility — often available to commercially insured).
   • Lilly patient support / Zepbound resources (if tirzepatide for weight management is an option).
   • These programs can dramatically lower out‑of‑pocket cost for commercially insured patients.

3. Patient assistance and discount services

   • NeedyMeds, Partnership for Prescription Assistance, PAN Foundation (check eligibility).
   • Prescription discount cards: GoodRx, SingleCare, Blink Health can reduce cash price for some GLP‑1s.

4. Consider other FDA‑approved options

   • Ozempic (semaglutide, Novo Nordisk) — diabetes indication but sometimes covered by insurers and used off‑label for weight.
   • Rybelsus (oral semaglutide) — oral option for diabetes.
   • Zepbound (tirzepatide, Eli Lilly) — approved for weight management; may have different coverage.
   • Mounjaro (tirzepatide for T2D, Lilly) — used for diabetes and sometimes accessible.
   • Saxenda (liraglutide, Novo Nordisk), Qsymia (phentermine/topiramate, Vivus), Contrave (naltrexone/bupropion, Orexigen) — older weight‑loss meds that insurers sometimes cover when Wegovy is denied.

5. Specialty pharmacies and weight‑management clinics

   • Ask your prescriber to work with a specialty pharmacy or an obesity medicine clinic — they often have staff to navigate prior authorizations and manufacturer programs.

If you’re still considering a compounded GLP‑1

• Only as a last resort, and only from a reputable, accredited sterile compounding pharmacy that:
  • Provides a certificate of analysis for ingredients, batch sterility testing, and explicit compounding source (not bulk, unregulated API), and follows USP standards.
• Ask your prescriber to weigh the benefits vs safety/quality risks and to document that FDA‑approved therapies were tried or are inaccessible.

If you want, I can:

• Draft appeal language your prescriber can use for a prior authorization or peer‑to‑peer.
• Look up patient assistance programs that match your insurance type (commercial vs Medicare/Medicaid) or local accredited compounding pharmacies to vet alternatives.

Which insurance (commercial, Medicare, Medicaid) and is the prescription for weight loss or diabetes? That will help me give concrete next steps.